i2S SA (ALI2S) Fair Value & Analysis
Industrials · FR · Market cap €10.2M
Fair value as of: Jun 24, 2026
Analysis
i2S SA (ALI2S) currently trades at €6.00, while our model-based Fair Value estimate is €6.30 — implying the stock looks roughly 5.0% undervalued today. We read business quality at 95/100 (high quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
i2S SA provides image capture and processing solution in France. The company offers heritage digitization solutions, including small book, large book, and V shape book scanners; a range of software solutions, such as LIMB Capture, a solution for digitization of projects; LIMB processing, a software for processing, enhancing, and converting cultural heritage into digital cultural heritage; LIMB Gallery, a digital library; and LIBM Maestro, a software for workflow supervision. It also provides health wellness solutions comprising in vitro diagnostic medical devices; connected portable tools; and e-health software solutions, as well as Irisolution platform. In addition, the company designs and develops custom industrial cameras; and inspection and data processing systems, as well as offers standard vision components. i2S SA was incorporated in 1979 and is headquartered in Pessac, France.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is i2S SA (ALI2S) undervalued?
What is the fair value of ALI2S?
What is the quality score of ALI2S?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.